The study and its comparison
Sixty-three women with fibromyalgia were randomized to three blinded treatment groups for six weeks: amitriptyline, melatonin, or both. Investigators measured pain, function and experimental pain modulation. [1]
Melatonin-containing groups had greater pain-score reductions than amitriptyline alone. The combination showed additional changes in selected functional and pain-threshold measures, which the authors described as only marginal added clinical effects. [1]
What the finding establishes
The small groups and short follow-up limit certainty. Without an inert-placebo-only arm, the comparison does not estimate each treatment’s full effect against no active medication. Funding and conflicts were not established from the abstract. The trial does not justify independently combining medicines or generalizing to every chronic-pain condition. [1]
A hypothetical distinction
Imagine all study groups receive an active treatment. Their differences answer a comparative question, not the same question as treatment versus placebo.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.